References
- 1. Apalla Z, Lallas A. Epidemiological trends in skin cancer. Dermatol Pract Concept 2017;7(2):1.10.5826/dpc.0702a01542465428515985
- 2. Urechescu HC, Balica NC. Basal cell carcinoma and basosquamous carcinoma, two faces of the same condition?, CA.Rom J Morphol Embryol. 2018, 59(3):989-996.
- 3. Oldbury JW, Wain RAJ. Basosquamous Carcinoma: A Single Centre Clinicopathological Evaluation and Proposal of an Evidence-Based Protocol. J Skin Cancer. 2018;2018:6061395.
- 4. Tarallo M, Cigna E. Metatypical basal cell carcinoma: a clinical review. J Exp Clin Cancer Res. 2008;27(1):65. Published 2008 Nov 7.10.1186/1756-9966-27-65258556018992138
- 5. Garcia C, Poletti E. Basosquamous carcinoma. J Am Acad Dermatol. 2009;60(1):137-143.10.1016/j.jaad.2008.09.03619103364
- 6. Bowman PH, Ratz JL. Basosquamous carcinoma. Dermatol Surg. 2003;29(8):830-833.
- 7. Burston J, Clay RD. The problems of histological diagnosis in basosquamous cell carcinoma of the skin. J Clin Pathol. 1959;12(1):73-79.10.1136/jcp.12.1.7347985413631086
- 8. LeBoit P. E. International Agency for Research on Cancer, World Health Organization, International Academy of Pathology, European Organization for Research on Treatment of Cancer, UniversitätsSpital Zürich, editors. Pathology And Genetics of Skin Tumors. Lyon, France: IARC Press; (World Health Organization classification of tumors).
- 9. Chiang A, Tan CZ. Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma. J Invest Dermatol. 2019;139(11):2263-2271.e5.10.1016/j.jid.2019.03.1163683954431207229
- 10. Jones MS, Helm KF. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg. 1997;23(3):181-184.10.1111/j.1524-4725.1997.tb00017.x9145960
- 11. Mitsuhashi T, Itoh T. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants. Journal of Cutaneous Pathology, 33: 246-252.10.1111/j.0303-6987.2006.00409.x16466514
- 12. Jankovic I, Kovacevic P. Application of sentinel lymph node biopsy in cutaneous basosquamous carcinoma. Ann Dermatol. Vol.23, Suppl. 1, 2011.10.5021/ad.2011.23.S1.S123319940822028558
- 13. Wermker K, Roknic N. Basosquamous carcinoma of the head and neck: clinical and histologic characteristics and their impact on disease progression. Neoplasia. 2015;17(3):301-305.10.1016/j.neo.2015.01.007437264625810014
- 14. Anand R, Collins D. Basosquamous carcinoma: appearance and reality. Oxford Medical Case Reports,2017;01,4-6.10.1093/omcr/omw095520955428058108
- 15. Martin RC 2nd,Edwards MJ. Basosquamous carcinoma:analysis of prognostic factors influencing recurrence. Cancer 2000, 15:1365-1369.10.1002/(SICI)1097-0142(20000315)88:6<1365::AID-CNCR13>3.0.CO;2-Y
- 16. H Dhouib, M Mnejja, L Ayadi, B Hammami, T Boudawara,et al. (2009) Carcinome basocellulaire metatypique. Anna d’Otolaryngologie et de Chirurgie Cervico-faciale 126: 25-28.10.1016/j.aorl.2008.10.005
- 17. Kumari, M.K, Srinivas C.H. Metatypical carcinoma: A rare case report. Journal of Clinical and Diagnostic Research. 6. 472-474.
- 18. Tan CZ, Rieger KE. Basosquamous Carcinoma: Controversy, Advances, and Future Directions. Dermatol Surg. 2017;43(1):23-31.10.1097/DSS.0000000000000815